40 related articles for article (PubMed ID: 11924525)
1. The chimeric multi-domain proteins mediating specific DNA transfer for hepatocellular carcinoma treatment.
Yang E; Li X; Jin N
Cancer Cell Int; 2016; 16():80. PubMed ID: 27752239
[TBL] [Abstract][Full Text] [Related]
2. Apoptin as a Tumor-Specific Therapeutic Agent: Current Perspective on Mechanism of Action and Delivery Systems.
Malla WA; Arora R; Khan RIN; Mahajan S; Tiwari AK
Front Cell Dev Biol; 2020; 8():524. PubMed ID: 32671070
[TBL] [Abstract][Full Text] [Related]
3. Cancer Treatment Goes Viral: Using Viral Proteins to Induce Tumour-Specific Cell Death.
Wyatt J; Müller MM; Tavassoli M
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817939
[TBL] [Abstract][Full Text] [Related]
4. Human serum albumin-mediated apoptin delivery suppresses breast cancer cell growth
Wu F; Liu Y; Li J; Hou L; Lei F; Huang S; Feng L; Zhao X
Oncol Lett; 2017 Feb; 13(2):579-586. PubMed ID: 28356932
[TBL] [Abstract][Full Text] [Related]
5. Tumor control by human cytomegalovirus in a murine model of hepatocellular carcinoma.
Kumar A; Coquard L; Pasquereau S; Russo L; Valmary-Degano S; Borg C; Pothier P; Herbein G
Mol Ther Oncolytics; 2016; 3():16012. PubMed ID: 27626063
[TBL] [Abstract][Full Text] [Related]
6. Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft.
Ismail R; Allaudin ZN; Abdullah R; Mohd Lila MA; Nik Abd Rahman NM; Abdul Rahman SO
BMC Cancer; 2016 Jul; 16():461. PubMed ID: 27411985
[TBL] [Abstract][Full Text] [Related]
7. Viral genes as oncolytic agents for cancer therapy.
Gupta SK; Gandham RK; Sahoo AP; Tiwari AK
Cell Mol Life Sci; 2015 Mar; 72(6):1073-94. PubMed ID: 25408521
[TBL] [Abstract][Full Text] [Related]
8. λ Phage nanobioparticle expressing apoptin efficiently suppress human breast carcinoma tumor growth in vivo.
Shoae-Hassani A; Keyhanvar P; Seifalian AM; Mortazavi-Tabatabaei SA; Ghaderi N; Issazadeh K; Amirmozafari N; Verdi J
PLoS One; 2013; 8(11):e79907. PubMed ID: 24278212
[TBL] [Abstract][Full Text] [Related]
9. Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinoma.
Zhang KJ; Qian J; Wang SB; Yang Y
J Biomed Sci; 2012 Feb; 19(1):20. PubMed ID: 22321574
[TBL] [Abstract][Full Text] [Related]
10. Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo.
Li X; Liu Y; Wen Z; Li C; Lu H; Tian M; Jin K; Sun L; Gao P; Yang E; Xu X; Kan S; Wang Z; Wang Y; Jin N
Mol Cancer; 2010 Jan; 9():10. PubMed ID: 20085660
[TBL] [Abstract][Full Text] [Related]
11. A mouse model for oral squamous cell carcinoma.
Schoop RA; Noteborn MH; Baatenburg de Jong RJ
J Mol Histol; 2009 Jun; 40(3):177-81. PubMed ID: 19685146
[TBL] [Abstract][Full Text] [Related]
12. Induction of an effective anti-tumor immune response and tumor regression by combined administration of IL-18 and Apoptin.
Lian H; Jin N; Li X; Mi Z; Zhang J; Sun L; Li X; Zheng H; Li P
Cancer Immunol Immunother; 2007 Feb; 56(2):181-92. PubMed ID: 16767432
[TBL] [Abstract][Full Text] [Related]
13. The viral protein Apoptin associates with the anaphase-promoting complex to induce G2/M arrest and apoptosis in the absence of p53.
Teodoro JG; Heilman DW; Parker AE; Green MR
Genes Dev; 2004 Aug; 18(16):1952-7. PubMed ID: 15314021
[TBL] [Abstract][Full Text] [Related]
14. The tumor-selective viral protein apoptin effectively kills human biliary tract cancer cells.
Pietersen AM; Rutjes SA; van Tongeren J; Vogels R; Wesseling JG; Noteborn MH
J Mol Med (Berl); 2004 Jan; 82(1):56-63. PubMed ID: 14647920
[TBL] [Abstract][Full Text] [Related]
15. Induction of insolubility by herpes simplex virus VP22 precludes intercellular trafficking of N-terminal Apoptin-VP22 fusion proteins.
Rutjes SA; Bosma PJ; Rohn JL; Noteborn MH; Wesseling JG
J Mol Med (Berl); 2003 Sep; 81(9):558-65. PubMed ID: 12879152
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy with apoptin induces regression of xenografted human hepatomas.
van der Eb MM; Pietersen AM; Speetjens FM; Kuppen PJ; van de Velde CJ; Noteborn MH; Hoeben RC
Cancer Gene Ther; 2002 Jan; 9(1):53-61. PubMed ID: 11924525
[TBL] [Abstract][Full Text] [Related]
17. Specific tumor-cell killing with adenovirus vectors containing the apoptin gene.
Pietersen AM; van der Eb MM; Rademaker HJ; van den Wollenberg DJ; Rabelink MJ; Kuppen PJ; van Dierendonck JH; van Ormondt H; Masman D; van de Velde CJ; van der Eb AJ; Hoeben RC; Noteborn MH
Gene Ther; 1999 May; 6(5):882-92. PubMed ID: 10505114
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
Yoon SK; Armentano D; Wands JR; Mohr L
Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
Liu L; Wu W; Zhu G; Liu L; Guan G; Li X; Jin N; Chi B
Int J Mol Med; 2012 Oct; 30(4):747-54. PubMed ID: 22842823
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
